Baricitinib Tablets IP In Stock
Pain-Killer

Baricitinib Tablets IP

Baricitinib Tablets IP is a JAK inhibitor used to manage rheumatoid arthritis and certain other inflammatory conditions under medical supervision.

Product Details

Baricitinib Tablets IP contains baricitinib, a Janus kinase (JAK) inhibitor used in the management of certain inflammatory and immune-mediated conditions. Depending on the approved indication, it may be prescribed for rheumatoid arthritis, alopecia areata, or other conditions under specialist supervision.

Key Benefits
- Helps manage symptoms of rheumatoid arthritis
- May reduce inflammation and joint-related symptoms
- Used in selected patients with alopecia areata
- Helps regulate excessive immune-system activity
- Supports long-term management of certain inflammatory conditions
How It Works
Baricitinib selectively inhibits JAK1 and JAK2 enzymes involved in intracellular signaling pathways used by various inflammatory cytokines. By reducing these signals, it helps control excessive immune and inflammatory activity.
Common Side Effects
- Upper respiratory tract infections
- Headache
- Nausea
- Acne
- Increased cholesterol levels
- Increased liver enzymes
- Low blood cell counts
- Herpes-related infections
Important Information
Baricitinib Tablets IP should be used only under the supervision of a qualified healthcare professional. It can increase the risk of serious infections and may affect blood counts, liver function, and cholesterol levels. Tuberculosis and other infections may need to be assessed before and during treatment. Baricitinib may also increase the risk of blood clots and certain cardiovascular events in some patients. Inform your doctor about infections, blood-clotting problems, heart conditions, liver or kidney disease, and all medicines you are taking. Seek urgent medical attention for severe infection symptoms, chest pain, breathing difficulty, or sudden swelling or pain in a limb.